PL2316425T3 - Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol - Google Patents

Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol

Info

Publication number
PL2316425T3
PL2316425T3 PL10188391T PL10188391T PL2316425T3 PL 2316425 T3 PL2316425 T3 PL 2316425T3 PL 10188391 T PL10188391 T PL 10188391T PL 10188391 T PL10188391 T PL 10188391T PL 2316425 T3 PL2316425 T3 PL 2316425T3
Authority
PL
Poland
Prior art keywords
glycerine
sorbitol
active agent
liquid formulations
formulations
Prior art date
Application number
PL10188391T
Other languages
English (en)
Inventor
William Bubnis
Stephanie Shield
Amanda Alley
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL2316425T3 publication Critical patent/PL2316425T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10188391T 2006-02-21 2007-02-16 Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol PL2316425T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77463406P 2006-02-21 2006-02-21
PCT/US2007/004310 WO2007098128A2 (en) 2006-02-21 2007-02-16 Phenylephrine-containing liquid formulations
EP07751095.6A EP1986606B1 (en) 2006-02-21 2007-02-16 Phenylephrine-containing liquid formulations
EP10188391.6A EP2316425B1 (en) 2006-02-21 2007-02-16 Liquid formulations comprising an active agent, glycerine and sorbitol

Publications (1)

Publication Number Publication Date
PL2316425T3 true PL2316425T3 (pl) 2019-01-31

Family

ID=38283964

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10188391T PL2316425T3 (pl) 2006-02-21 2007-02-16 Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol
PL07751095T PL1986606T3 (pl) 2006-02-21 2007-02-16 Ciekłe formulacje zawierające fenylefrynę

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07751095T PL1986606T3 (pl) 2006-02-21 2007-02-16 Ciekłe formulacje zawierające fenylefrynę

Country Status (12)

Country Link
US (4) US8940796B2 (pl)
EP (2) EP1986606B1 (pl)
AU (1) AU2007217799B2 (pl)
CA (1) CA2642048C (pl)
ES (2) ES2728823T3 (pl)
HU (2) HUE043620T2 (pl)
PE (2) PE20071310A1 (pl)
PL (2) PL2316425T3 (pl)
PT (2) PT1986606T (pl)
TR (2) TR201815803T4 (pl)
TW (1) TWI482620B (pl)
WO (1) WO2007098128A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8940796B2 (en) 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2007254819A1 (en) * 2006-06-01 2007-12-13 Schering Corporation Phenylphrine pulsed release formulations and pharmaceutical compositions
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
AU2007254826B2 (en) * 2006-06-01 2013-10-24 Merck Sharp & Dohme Corp. Pharmaceutical compositions for sustained release of phenyephrine
ES2391585T3 (es) * 2006-06-01 2012-11-28 Msd Consumer Care, Inc. Formulación farmacéutica de liberación sostenida que comprende fenilefrina
EP2164472A1 (en) * 2007-06-01 2010-03-24 Schering-Plough Healthcare Products, Inc. Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015137829A1 (en) * 2014-03-12 2015-09-17 Angeles Relinda G Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
AU2015290098B2 (en) 2014-07-17 2018-11-01 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
CN104922124B (zh) * 2015-05-28 2017-06-30 华润三九医药股份有限公司 一种肾素那敏片及其制备方法
CN104983732B (zh) * 2015-05-28 2018-05-04 华润三九医药股份有限公司 一种布洛肾素那敏片及其制备方法
WO2020013973A1 (en) * 2018-07-09 2020-01-16 Bayer Healthcare Llc An aqueous-based composition containing xantan gum as inhibitor of microbial growth
CN109125257B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚愈创肾素口服液及其制备方法
CN109044968B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚右美肾素口服液及其制备方法
CN109045003B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚拉明肾素口服液及其制备方法
US12539314B1 (en) * 2019-03-07 2026-02-03 Genus Lifesciences Inc. Aqueous oral compositions including potassium chloride
CN110327339A (zh) * 2019-08-07 2019-10-15 北京博达绿洲医药科技研究有限公司 一种复方右美沙芬口服溶液及其制备方法和用途
CN110507607A (zh) * 2019-09-27 2019-11-29 葵花药业集团北京药物研究院有限公司 苯海拉明肾素口服液及其制备方法和用途
AU2020410965B2 (en) 2019-12-23 2025-12-11 Farmalíder, S.A Liquid composition comprising ibuprofen and phenylephrine
US20210228507A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine Hydrochloride Compositions and Containers
CN111450051B (zh) * 2020-04-21 2022-03-18 武汉贝参药业股份有限公司 一种富马酸酮替芬口服溶液的制备方法
CN112076183A (zh) * 2020-08-28 2020-12-15 北京博达绿洲医药科技研究有限公司 包含盐酸去氧肾上腺素液体组合物
CN112402416A (zh) * 2020-12-18 2021-02-26 北京博达绿洲医药科技研究有限公司 一种治疗感冒的复方液体制剂及其制备方法
CN113081958B (zh) * 2021-05-01 2022-05-03 安徽新世纪药业有限公司 一种地氯雷他定口服溶液及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
AU670567B2 (en) 1992-03-05 1996-07-25 American Home Products Corporation Pharmaceutical coated cores
US5405604A (en) * 1992-10-16 1995-04-11 The Procter & Gamble Company Concentrated mouthrinse for efficient delivery of antimicrobials
AU3154895A (en) * 1994-08-01 1996-03-04 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
EP0901787B1 (en) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
DE69901936T2 (de) * 1998-01-30 2002-11-28 Novartis Consumer Health S.A., Nyon Nasale lösungen
US20010053775A1 (en) * 1998-01-30 2001-12-20 Matthias Seidel Nasal solutions
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
CA2455939C (en) * 2001-07-31 2011-03-22 Wyeth Llc Sucralose formulations to mask unpleasant tastes
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
WO2005070390A2 (en) * 2004-01-21 2005-08-04 Janssen Pharmaceutica N.V. Mitratapide oral solution
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) * 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
NZ555909A (en) 2004-12-13 2009-11-27 Mcneil Ppc Inc Compositions and methods for reducing the degradation of phenylephrine by oxygen
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US8940796B2 (en) 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2007254819A1 (en) 2006-06-01 2007-12-13 Schering Corporation Phenylphrine pulsed release formulations and pharmaceutical compositions

Also Published As

Publication number Publication date
AU2007217799A1 (en) 2007-08-30
US8940796B2 (en) 2015-01-27
EP2316425A1 (en) 2011-05-04
HUE043620T2 (hu) 2019-08-28
PE20110010A1 (es) 2011-01-12
US20070197661A1 (en) 2007-08-23
WO2007098128A3 (en) 2007-10-11
EP2316425B1 (en) 2018-08-29
EP1986606A2 (en) 2008-11-05
PT2316425T (pt) 2018-11-13
PE20071310A1 (es) 2007-12-12
AU2007217799B2 (en) 2012-12-13
ES2728823T3 (es) 2019-10-28
ES2692890T3 (es) 2018-12-05
TR201906970T4 (tr) 2019-06-21
TWI482620B (zh) 2015-05-01
US20190209688A1 (en) 2019-07-11
WO2007098128A2 (en) 2007-08-30
US9801941B2 (en) 2017-10-31
PL1986606T3 (pl) 2019-08-30
CA2642048A1 (en) 2007-08-30
US20150150976A1 (en) 2015-06-04
EP1986606B1 (en) 2019-04-10
CA2642048C (en) 2015-11-24
TW200800143A (en) 2008-01-01
US11406712B2 (en) 2022-08-09
US11419938B2 (en) 2022-08-23
US20170333561A1 (en) 2017-11-23
HUE039382T2 (hu) 2018-12-28
PT1986606T (pt) 2019-06-12
TR201815803T4 (tr) 2018-11-21

Similar Documents

Publication Publication Date Title
PT2316425T (pt) Formulações líquidas compreendendo um agente ativo, glicerina e sorbitol
IL196108A0 (en) Active agent formulations, methods of making, and methods of use
IL184563A (en) Pharmaceutical foam formulations and their use
IL193274A0 (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
EP2070075A4 (en) MESSAGING WITH ACTIVE RESPONSE CHARACTERISTICS
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL194688A0 (en) Rapid acting and long acting insulin combination formulations
ZA200902920B (en) Composition comprising oligogalacturonans and polycationic saccharides
PL2594248T3 (pl) Połączenie składników czynnych i jego zastosowanie
IL202770A0 (en) Active ingredient suspensions in glycerine
PL3001905T3 (pl) Kombinacje substancji czynnej o właściwościach owadobójczych i roztoczobójczych
IL199904A0 (en) Compositions comprising a therapeutic agent and an alkoxy-polyethylene glycol and uses thereof
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
PL2923576T3 (pl) Kombinacje substancji czynnych o właściwościach owadobójczych i roztoczobójczych
IL173762A0 (en) A device and method for the prolonged delivery of an active agent to a body cavity
IL209029A0 (en) Condom with localized active agent
PL2084272T3 (pl) Klonowanie, ekspresja oraz zastosowanie kwaśnych lizofosfolipaz
PL1795186T3 (pl) Preparat leku zawierający flupirtynę o kontrolowanym uwalnianiu substancji czynnej
IL197072A0 (en) Aqueous formulation comprising an antitumor agent
ZA200805938B (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
IL213252A0 (en) Agrochemical formulations containing pyrrloidone alkylene oxides
GB0503509D0 (en) An improved delivery agent
GB0614393D0 (en) Perfume Formulation
ZA200804086B (en) Stable pharmaceutical formulations containing escitalo-pram and bupropion
IL207650A0 (en) A gelatin sponge comprising an active ingredient, its preparation and use